On September 27, 2026, the U.S. District Court for the District of Connecticut ruled on summary judgment in Concannon v. LEGO Systems, Inc., No. 3:21-cv-01678 (D. Conn.). At the heart of the case are a jacket worn by Antoni Porowski
On Sept. 29, the USPTO issued another memorandum as well as a new flowchart addressing applicant “subject matter eligibility declarations” (SMEDs) submitted to establish eligibility under Section 101. This is now the third time the office has issued guidance on
AI developers who train large language models on copyrighted code just cleared a significant legal hurdle. On September 16, 2026, the 9th Circuit affirmed dismissal of the plaintiffs’ claim in Doe v. GitHub, Inc. under Section 1202(b) of the Digital
In VDPP v. Volkswagen, the Federal Circuit made short work of rejecting VDPP’s argument that settlement licenses are somehow different from ordinary licenses for marking purposes. Following up on Seeing More Clearly: Patent Marking Compliance in the Wake of
Is a pop star’s voice a trademark? Taylor Swift’s legal team is betting yes. On April 24, 2026, she filed three applications with the United States Patent and Trademark Office (USPTO) seeking federal registration of two sound marks and one
Following up on What VDPP v. Volkswagen Could Mean for Patent Settlements and Marking and aspects of No Spectacle Worth Watching: How a Non-Practicing Entity’s Failure to Mind Its Licensees Cost It the Case, the Federal Circuit’s decision in
Trade secret lawyers commonly assert claims under both the federal Defend Trade Secrets Act (“DTSA”) and the applicable state’s version of the Uniform Trade Secrets Act (“UTSA”). But in doing so, they might overlook differences in the key elements and
The Federal Circuit’s decision in VDPP, LLC v. Volkswagen Group of America, Inc. offers a clear-eyed look at three recurring pain points in patent litigation: what it takes to plead, what is “exceptional” under 35 U.S.C. § 285, and what
In a decisive reversal, the Federal Circuit handed Boston Scientific Corporation a complete victory in Board of Regents of the University of Texas System v. Boston Scientific Corp., vacating a jury verdict that had found Boston Scientific’s drug-eluting coronary
A new rule from the USPTO took effect July 20, effectively ending foreign pro se patent prosecution: Patent applicants and patent owners whose domicile is outside the United States or its territories must now be represented by a registered patent
